Patent details

EP2182902 Title: COMPOSITIONS COMPRISING SUFENTANIL AND TRIAZOLAM FOR PROCEDURAL SEDATION AND ANALGESIA USING ORAL TRANSMUCOSAL DOSAGE FORMS

Basic Information

Publication number:
EP2182902
PCT Application Number:
PCT/US/2008/072445
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087973632
PCT Publication Number:
WO/2009/021106
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOSITIONS COMPRISING SUFENTANIL AND TRIAZOLAM FOR PROCEDURAL SEDATION AND ANALGESIA USING ORAL TRANSMUCOSAL DOSAGE FORMS
French Title of Invention:
COMPOSITIONS COMPRENANT DU SUFENTANIL AND DE LA TRIAZOLAME POUR LEUR UTILISATION DANS LA SÉDATION ET L'ANALGÉSIE PROCÉDURALES UTILISANT LES FORMES POSOLOGIQUES TRANSMUCOSALES ORALES
German Title of Invention:
ZUSAMMENSETZUNGEN MIT SUFENTANIL UND TRIAZOLAM ZUR SEDIERUNG UND ANALGESIE BEI EINGRIFFEN MIT ORALEN TRANSMUKOSALEN DOSIERFORMEN
SPC Number:

Dates

Filing date:
07/08/2008
Grant date:
07/01/2015
EP Publication Date:
07/01/2015
PCT Publication Date:
12/02/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/05/2010
EP B1 Publication Date:
07/01/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/08/2015
Expiration date:
07/08/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/03/2015
 
 

Name:
AcelRx Pharmaceuticals Inc.
Address:
351 Galveston Dr, Redwood City, CA 94063, United States (US)

Inventor

1

Name:
PALMER Pamela
Address:
United States (US)

2

Name:
TZANNIS Stelios
Address:
United States (US)

3

Name:
SCHRECK Thomas
Address:
United States (US)

Priority

Priority Number:
954501 P
Priority Date:
07/08/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/70;

Publication

European Patent Bulletin

Issue number:
201733
Publication date:
16/08/2017
Description:
Opposition rejected; Patent maintained as granted

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages